Assessing Nanobiotix (ENXTPA:NANO) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
Nanobiotix S.A. - ADSs (NBTX)
Company Research
Source: Yahoo! Finance
What recent performance says about Nanobiotix Nanobiotix (ENXTPA:NANO) has caught investors attention after a recent one-day return of 2.2% moved alongside a one-month gain of 6.1% and a past three-month return of 51.2%. Those moves come against a backdrop of annual revenue of €32.593 million, a reported net loss of €23.961 million and a market value of about €1.36b. This highlights a clinical stage biotech profile with ongoing development spend. See our latest analysis for Nanobiotix. The current share price of €28.12 sits against a 30 day share price return of 6.1% and a 90 day gain of 51.2%. The one year total shareholder return is very large, suggesting momentum has been strong over both shorter and longer periods as expectations around Nanobiotix's cancer pipeline and risk profile have shifted. If you are curious about other potential growth stories in this space, it could be worth scanning a curated list of 127 healthcare AI stocks With Nanobiotix sharing clinical s
Show less
Read more
Impact Snapshot
Event Time:
NBTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NBTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NBTX alerts
High impacting Nanobiotix S.A. - ADSs news events
Weekly update
A roundup of the hottest topics
NBTX
News
- Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology [Yahoo! Finance]Yahoo! Finance
- Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer TechnologyGlobeNewswire
- Voting Rights and Shares Capital of the CompanyGlobeNewswire
- Nanobiotix (NBTX) had its price target raised by Guggenheim from $26.00 to $36.00. They now have a "buy" rating on the stock.MarketBeat
- Nanobiotix S.A. (NBTX) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
NBTX
Sec Filings
- 3/12/26 - Form 6-K
- 2/25/26 - Form 6-K
- NBTX's page on the SEC website